Field-effect transistor bioassay for ultrasensitive detection of folate receptor 1 by ligand-protein interaction
- 4 November 2020
- journal article
- research article
- Published by Springer Nature in Microchimica Acta
- Vol. 187 (12) , 1-11
Abstract
A miniaturized and integrated bioassay was developed based on molybdenum disulfide (MoS2) field-effect transistor (FET) functionalized with bovine serum albumin-folic acid (BSA-FA) for monitoring FOLR1. We performed the electrical test of FOLR1 within the range 100 fg/mL to 10 ng/mL, and the limit of detection was 0.057 pg/mL. The ultrahigh sensitivity of the bioassay was realized by ligand-protein interaction between FA and FOLR1, with a ligand-protein binding ratio of 3:1. The formation of FA-FOLR1 was confirmed with ELISA. The binding affinity dissociation constant KD was 12 ± 6 pg/mL. This device can work well for FOLR1 detection in human serum, which presents its promising application in point-of-care diagnosis. This study supports the future applications of such ligand-protein-based bioassays in the clinical practices. MoS2-based FET device for detecting folate receptor 1 (FOLR1) was fabricated. The molecular folic acid as a probe can specifically bound to FOLR1 with a high affinity.Keywords
Funding Information
- National Natural Science Foundation of China (No. 21975067)
- Technology Innovation Program of Hunan Province (No. 2018RS3060)
This publication has 65 references indexed in Scilit:
- Predicting breast cancer metastasis by using serum biomarkers and clinicopathological data with machine learning technologiesInternational Journal of Medical Informatics, 2019
- Improved Statistical Methods for Evaluation of Stability of In Vitro Diagnostic ReagentsStatistics in Biopharmaceutical Research, 2017
- Validation of a Novel Biomarker Panel for the Detection of Ovarian CancerCancer Epidemiology, Biomarkers & Prevention, 2016
- Point-of-Care TestingJournal of Pharmacy Practice, 2016
- Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testingBiotechnology Advances, 2016
- The Value of In Vitro Diagnostic Testing in Medical Practice: A Status ReportPLOS ONE, 2016
- A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerDrug Design, Development and Therapy, 2015
- High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and MutationJournal of Thoracic Oncology, 2012
- Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic SignificanceOncotarget, 2012
- The α folate receptor is highly activated in malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2001